AIM VACCINE CO LTD revenue breakdown overview

AIM VACCINE CO LTD revenue for the last year amounted to 1.37 B HKD, the most of which — 1.22 B HKD — came from its highest performing source at the moment, Class II Vaccine, the year earlier bringing 1.23 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought AIM VACCINE CO LTD 1.39 B HKD, and the year before that — 1.31 B HKD.